These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 4012049)

  • 1. [Usefulness of glucocorticoids in the treatment of congestive heart failure].
    Inagaki Y; Nakayama A; Ishide T
    Kokyu To Junkan; 1985 Mar; 33(3):253-5. PubMed ID: 4012049
    [No Abstract]   [Full Text] [Related]  

  • 2. Digoxin affects potassium homeostasis during exercise in patients with heart failure.
    Schmidt TA; Bundgaard H; Olesen HL; Secher NH; Kjeldsen K
    Cardiovasc Res; 1995 Apr; 29(4):506-11. PubMed ID: 7796444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is energetic-dynamic heart failure only a syndrome?].
    Hegglin R; Turina M; Krayenbühl HP
    Schweiz Med Wochenschr; 1969 May; 99(19):693-8. PubMed ID: 5785436
    [No Abstract]   [Full Text] [Related]  

  • 4. The biphasic action of cardiac glycosides on the Na+, K+-pump and its relevance in the treatment of heart failure.
    Godfraind T
    Eur Heart J; 1982 Dec; 3 Suppl D():53-7. PubMed ID: 6297911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of large doses of potassium chloride on potassium and sodium metabolism and on the acid-base equilibrium in patients with cardiac insufficiency].
    Votchal BE; Kabakov AI
    Vrach Delo; 1967; 9():59-62. PubMed ID: 5621783
    [No Abstract]   [Full Text] [Related]  

  • 6. [The comparative effect of camphor and caffeine on certain indices of mineral metabolism in cardiac insufficiency].
    Dmitrieva NM; Samilova RD
    Vrach Delo; 1968 Feb; 2():31-3. PubMed ID: 5669357
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure.
    Hwang GS; Oh KS; Koo HN; Seo HW; You KH; Lee BH
    Eur J Pharmacol; 2006 Jul; 540(1-3):131-8. PubMed ID: 16729997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fallacies and facts about digitalis and congestive heart failure.
    Walker WJ
    Geriatrics; 1972 Mar; 27(3):73-6. PubMed ID: 5011204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrolyte metabolism of the myocardium in cardiac insufficiency].
    Sokolov EI
    Ter Arkh; 1966 Dec; 39(12):61-5. PubMed ID: 6004399
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart.
    Neumann H
    Geriatrics; 1966 Jun; 21(6):180-5. PubMed ID: 5949184
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sodium and water metabolism of the myocardium in normal state and during cardiac insufficiency].
    Sokolov EI
    Sov Med; 1967 Aug; 30(8):25-30. PubMed ID: 5610592
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ion metabolism of the healthy and insufficient heart].
    Heinrich K
    Med Klin; 1969 May; 64(18):819-22. PubMed ID: 4239496
    [No Abstract]   [Full Text] [Related]  

  • 14. Another calcium paradox in heart failure.
    Kass RS; Lindegger N; Hagen B; Lederer WJ
    J Mol Cell Cardiol; 2008 Jul; 45(1):28-31. PubMed ID: 18504047
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical-pharmacological aspects of the evaluation of digitalis effect].
    Hochrein H
    Arzneimittelforschung; 1969 May; 19(5):791-4. PubMed ID: 4240674
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.
    Nobel-Allen N; Kirsch M; Lucchesi BR
    J Pharmacol Exp Ther; 1973 Dec; 187(3):475-81. PubMed ID: 4770394
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of diuretics in congestive heart failure. A detailed study in four patients.
    Mahabir RN; Laufer ST
    Arch Intern Med; 1969 Jul; 124(1):1-7. PubMed ID: 5791481
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of intravenous morphine in patients with mitral valvular disease and congestive heart failure.
    Grendahl H; Andersen A; Müller C
    Acta Med Scand; 1973; 1-2(1):69-74. PubMed ID: 4727250
    [No Abstract]   [Full Text] [Related]  

  • 19. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure.
    Motro M; Freimark D; Feinberg MS; Wynne RD; King C; Schneeweiss A
    Int J Clin Pharmacol Res; 1993; 13(3):143-9. PubMed ID: 8225697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
    Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.